Immune responses to human cancer stem-like cells/cancer-initiating cells
about
Dendritic-Tumor Fusion Cell-Based Cancer VaccinesBrother of the regulator of the imprinted site (BORIS) variant subfamily 6 is a novel target of lung cancer stem-like cell immunotherapy.Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.Aloe-emodin inhibits HER-2 expression through the downregulation of Y-box binding protein-1 in HER-2-overexpressing human breast cancer cellsPeptide vaccination therapy: Towards the next generation.Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer.Approaches for targeting cancer stem cells drug resistance.Implication of chemo-resistant memory T cells for immune surveillance in patients with sarcoma receiving chemotherapy.Phosphorylation of HSF1 at serine 326 residue is related to the maintenance of gynecologic cancer stem cells through expression of HSP27.CXorf48 is a potential therapeutic target for achieving treatment-free remission in CML patients.Cellular stress induces cancer stem-like cells through expression of DNAJB8 by activation of HSF1.Cancer stem cells as targets for immunotherapy.CD169-positive sinus macrophages in the lymph nodes determine bladder cancer prognosis.Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG.Potential function of CTLA-4 in the tumourigenic capacity of melanoma stem cellsExploring immuno-regulatory mechanisms in the tumor microenvironment: Model and design of protocols for cancer remissionCancer stem cells as targets for DC-based immunotherapy of colorectal cancer
P2860
Q26744827-55CB9082-5876-4BA8-83BC-9963E2634F42Q36293822-779AE1CE-3B5D-4512-B3F6-E6C80B49D2BFQ36998205-402EAD00-87A7-4B56-84D1-94B3AF5216FFQ37644791-92FFF9D5-011C-4DCB-A761-BECA32F332AAQ38902336-2AA0504C-3188-4272-9770-3C80DE219004Q38935248-A2070DB4-5F15-4ED9-A811-3FE1DACD8845Q38971795-E2F7A8E1-694E-45D8-A38A-2362C1A5A4A5Q41595465-799727E1-A2BA-482A-AC70-D09B9ED3D411Q42137660-87878184-C091-42CA-ACD0-0041D0532D31Q47099925-3003F090-1A5E-4A8C-9E19-B57D30F368D2Q47217802-3E846574-5DF9-481C-80A1-100BD412ED62Q48278683-5643CE6F-472E-4FD3-8AB8-EA67FBB8ABF1Q52665317-7A5B2905-8E08-4AA2-9291-BF072316E876Q55424304-ACA38B8A-5F6D-4703-B7EB-FF4E604A737EQ57788678-F40F17AC-4A68-4CF1-AC83-3D47967AE2D2Q58763679-4F757A44-23CD-476F-9A02-8328BE1D135BQ58786746-7A9EFD8A-8531-432A-A094-87C1683ED2FB
P2860
Immune responses to human cancer stem-like cells/cancer-initiating cells
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Immune responses to human cancer stem-like cells/cancer-initiating cells
@ast
Immune responses to human cancer stem-like cells/cancer-initiating cells
@en
Immune responses to human cancer stem-like cells/cancer-initiating cells
@nl
type
label
Immune responses to human cancer stem-like cells/cancer-initiating cells
@ast
Immune responses to human cancer stem-like cells/cancer-initiating cells
@en
Immune responses to human cancer stem-like cells/cancer-initiating cells
@nl
prefLabel
Immune responses to human cancer stem-like cells/cancer-initiating cells
@ast
Immune responses to human cancer stem-like cells/cancer-initiating cells
@en
Immune responses to human cancer stem-like cells/cancer-initiating cells
@nl
P2093
P2860
P3181
P356
P1433
P1476
Immune responses to human cancer stem-like cells/cancer-initiating cells
@en
P2093
Noriyuki Sato
Takayuki Kanaseki
Tomohide Tsukahara
Toshihiko Torigoe
Vitaly Kochin
Yoshihiko Hirohashi
P2860
P3181
P356
10.1111/CAS.12830
P407
P5008
P577
2016-01-01T00:00:00Z